As clinical research shifts toward patient-centric models, Dongguan Trial Medical Co., Ltd. stands at the forefront of the IoT revolution, providing the hardware backbone for modern medical data acquisition.
Established in 2016 in Dongguan, China, we operate an 11,000 square meter facility dedicated to medical technology innovation. With over 230 employees, we bridge the gap between complex IoT engineering and stringent clinical requirements.
Our portfolio includes remote monitoring devices, wearable health collection systems, and eCOA (Electronic Clinical Outcome Assessment) tools designed to streamline study management and enhance operational efficiency for global CROs.
Our experienced team of engineers and software developers continuously invests in R&D to address the evolving needs of decentralized trials, integrating cloud-based data management and intelligent monitoring.
Navigating FDA 21 CFR Part 11 and GDPR is non-negotiable. Our IoT solutions feature end-to-end encryption and audit trails, ensuring that patient data remains secure from the wearable sensor to the cloud repository.
To support global enterprises, we offer localized server configurations. Whether your trial is in the EU, North America, or APAC, we ensure data residency compliance through flexible IoT architecture.
Based in Dongguan, the "World's Factory," we leverage a hyper-efficient ecosystem for medical-grade components. This allows for rapid prototyping and cost-effective scaling that Western manufacturers cannot match.
Visual documentation of our 11,000sqm manufacturing excellence and R&D facilities in Dongguan.
Modern clinical trials no longer rely on sporadic clinic visits. Our IoT devices enable the collection of passive data—continuous heart rate variability, sleep patterns, and gait analysis. This "Information Gain" provides a more holistic view of patient health, reducing the sample size needed for statistical significance.
The biggest challenge in clinical research is patient dropout. By utilizing our OEM IoT Solutions, participants can contribute data from the comfort of their homes. Our devices are designed with intuitive interfaces, reducing the "technology burden" on elderly or chronically ill patients.
Global pharmaceutical companies are diversifying their hardware procurement. Dongguan Trial Medical offers a balanced approach: high-tier engineering combined with flexible volume production. Our OEM/ODM services allow research centers to brand and customize devices to specific study protocols, ensuring perfect alignment with trial objectives.
Real-time vital sign monitoring in early-stage trials to detect Adverse Events (AEs) immediately, ensuring participant safety and rapid data iteration.
Long-term data collection for diabetes or cardiovascular trials, utilizing GPRS/LoRaWAN enabled devices for consistent data transmission in rural areas.
Reducing the need for cancer patients to travel to specialized centers by using our mobile assessment tools and remote safety monitoring systems.
Our devices undergo rigorous validation for accuracy, repeatability, and data integrity. We adhere to ISO 13485 standards and ensure all digital transmissions comply with HIPAA and GxP guidelines.
Yes. As an OEM/ODM specialist, we provide full firmware customization, allowing researchers to set specific sampling rates, data triggers, and on-device patient notifications.
We have an established logistics network serving North America, Europe, and the Middle East. We manage the complexities of medical device importation and provide technical support for localized deployment.
Standard prototyping typically takes 4-6 weeks. Full-scale production timelines depend on the complexity of the sensor integration but are significantly accelerated by our localized supply chain in Dongguan.
Trial Medical
